Study of Neoadjuvant Cemiplimab for Stage II to IV (M0) Cutaneous Squamous Cell Carcinoma (R2810-ONC-1901)
Study of Neoadjuvant Cemiplimab for Stage II to IV (M0) Cutaneous Squamous Cell Carcinoma (R2810-ONC-1901)
Trial Category:
Other Solid Tumor
Phase
II
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
